Investor Relations – Silo Wellness

Loading...

Investor Relations

Investor RelationsSaroja Lewis2021-05-12T11:05:06+00:00

SILO WELLNESS

234 Eglinton Ave East
Suite 501
Toronto, ON
M4P 1K5

For further information please contact Silo Wellness Investor Relations at (604) 343-2724.

IR@silowellness.com

Press Releases:

Silo Wellness Partners with Kaivalya Kollectiv to Include 5-MeO-DMT In Psychedelic Portfolio Offering

Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica

Silo Wellness Appoints Phytomedicine Business Leader as Board Member

Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray in Colombia and Brasil

Psychedelics Company Silo Wellness Expands its Shareholder Base to Europe by Commencing Trading on the German Börse Frankfurt (FRA) Exchange Under Ticker Symbol “3K70”

Silo Wellness Hires Two Veterans of Lifestyle Marketing and Cannabis Industry to Promote Marley Line of Functional & Psychedelic Mushroom Brand

Psilocybin Data Study Agreement Reached Between Silo Wellness and Ehave Using Brain Scientific Mapping Neurocap

Silo Wellness Secures Global Marley IP Agreement

Silo Wellness Kicks Off Second Oregon Psychedelic Wellness Retreat

Silo Wellness Commences Trading on the Canadian Securities Exchange

Yukoterre Announces Conditional Approval of Reverse Takeover Transaction With Silo Wellness

Silo Wellness Announces the First-of-Its-Kind U.S.-Legal Psychedelic Wellness Nature Retreat in Oregon

Silo Wellness Closes $2.5 Million Subscription Receipt Financing With Another $2.4 Million in Escrow

Corporate Collateral: